Once the main hurdles to stem cell-based therapies are overcome, translation to clinical practice will greatly improve the quality of life of people with type 1 diabetes mellitus.
[European Journal of Pharmaceutical Sciences]
7992332
{7992332:BBBBBBBB}
apa
50
1
172141
https://www.stemcellsciencenews.com/wp-content/plugins/zotpress/
